EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

De Ritis (AST/ALT) ratio as a predictor of early adverse outcomes following transcatheter aortic valve replacement

Haitham Abu Khadija iD, Jebrin Alkrinawi, Ali Abdullah, Omar Ayyad, Ammar Barakat, Salma Najjar iD, Alexander Kogan, Leonid Sternik, Alaa Shehady iD, Mohammad Masu'd, Duha Najajra, Mohammad Alnees iD

PLOS One · 28.07.2026 · 21 (7) · e0354267

DOI: 10.1371/journal.pone.0354267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 28.07.2026. Verfasst von Haitham Abu Khadija und 11 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center, Kaplan Medical Center, Rehovot, affiliated with the Hebrew University, Jerusalem, Israel. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aspartate Aminotransferases, Alanine Transaminase, Aortic Valve Stenosis. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Simple biochemical markers that capture systemic stress could refine short-term risk stratification after TAVR. We evaluated whether an elevated AST/ALT ratio predicts early adverse outcomes following transfemoral TAVR.

Methods

We retrospectively analyzed 733 consecutive patients undergoing transfemoral TAVR. The exposure was the preprocedural AST/ALT ratio categorized as low (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAspartate AminotransferasesAlanine TransaminaseAortic Valve StenosisPostoperative ComplicationsHumansFemaleRetrospective StudiesMaleAcute Kidney InjuryAged, 80 and overAgedStrokeBiomarkersAtrial FibrillationProportional Hazards ModelsRisk FactorsTreatment OutcomeKaplan-Meier Estimate

Substanzen

Aspartate AminotransferasesAlanine TransaminaseBiomarkers

Autor:innen und Institutionen

  • Heart Center, Kaplan Medical Center, Rehovot, affiliated with the Hebrew University, Jerusalem, Israel.
  • Institute of Gastroenterology and Liver Disease, Kaplan Medical Center, Rehovot, Israel, affiliated with the Hebrew University, Jerusalem, Israel.
  • Department of Internal Medicine B, Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Cardiac Surgery, The Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Hashomer, Israel.
  • Gray Faculty of Medical and Health Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv-Yafo, Israel.
  • Harvard Medical School, Postgraduate Medical Education, Global Clinical Scholar Research Training Program, Boston, Massachusetts, United States of America.

ORCID-Profile: Haitham Abu Khadija, Salma Najjar, Alaa Shehady, Mohammad Alnees

Zitieren

APA

Abu Khadija, H., Alkrinawi, J., Abdullah, A., Ayyad, O., Barakat, A., Najjar, S., Kogan, A., Sternik, L., Shehady, A., Masu'd, M., Najajra, D., & Alnees, M. (2026). De Ritis (AST/ALT) ratio as a predictor of early adverse outcomes following transcatheter aortic valve replacement. PLOS One, 21(7), e0354267. https://doi.org/10.1371/journal.pone.0354267

Vancouver

Abu Khadija H, Alkrinawi J, Abdullah A, Ayyad O, Barakat A, Najjar S, et al. De Ritis (AST/ALT) ratio as a predictor of early adverse outcomes following transcatheter aortic valve replacement. PLOS One. 2026;21(7):e0354267. doi:10.1371/journal.pone.0354267

BibTeX
@article{AbuKhadija2026,
  author = {Abu Khadija, Haitham and Alkrinawi, Jebrin and Abdullah, Ali and Ayyad, Omar and Barakat, Ammar and Najjar, Salma and Kogan, Alexander and Sternik, Leonid and Shehady, Alaa and Masu'd, Mohammad and Najajra, Duha and Alnees, Mohammad},
  title = {De Ritis (AST/ALT) ratio as a predictor of early adverse outcomes following transcatheter aortic valve replacement},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0354267},
  doi = {10.1371/journal.pone.0354267}
}
Kostenlos starten →